share_log

維亞生物：截至二零二四年一月三十一日止月份股份發行人的證券變動月報表

VIVA BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2024

香港交易所 ·  Feb 1 23:32
Summary by Moomoo AI
维亚生物科技控股集团（「本公司」）於2024年2月2日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年1月31日的公司股份變動情況。報告顯示，本公司的法定/註冊股本在報告期內無變動，上月底結存及本月底結存均為4,000,000,000股，每股面值0.000025美元，法定/註冊股本總額維持在100,000美元。此外，本公司的股份期權計劃中，首次公開發售前股份獎勵計劃及首次公開發售後購股權計劃的股份期權數目在本月內均無變動。本公司確認，所有證券發行均已獲董事會正式授權批准，並符合相關法律規定。
维亚生物科技控股集团（「本公司」）於2024年2月2日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年1月31日的公司股份變動情況。報告顯示，本公司的法定/註冊股本在報告期內無變動，上月底結存及本月底結存均為4,000,000,000股，每股面值0.000025美元，法定/註冊股本總額維持在100,000美元。此外，本公司的股份期權計劃中，首次公開發售前股份獎勵計劃及首次公開發售後購股權計劃的股份期權數目在本月內均無變動。本公司確認，所有證券發行均已獲董事會正式授權批准，並符合相關法律規定。
VIA BIOTECHNOLOGY HOLDINGS GROUP (THE “COMPANY”) FILED AN UPDATED SECURITIES CHANGE MONTH REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON FEBRUARY 2, 2024, REPORTING CHANGES IN COMPANY SHARES AS OF 31 JANUARY 2024. THE REPORT SHOWS THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL REMAINED UNCHANGED DURING THE REPORTING PERIOD, WITH 4,000,000,000 SHARES DEPOSITED AT THE END OF LAST MONTH AND DEPOSITS AT THE END OF THIS MONTH AT $0.000025 PER SHARE, AND THE TOTAL STATUTED/REGISTERED SHARE CAPITAL REMAINED AT $100,000. In addition, the number of share options under the Initial Public Offering Share Award Scheme and the Initial Public Post-IPO Share Option Plan remained unchanged during the month. The Company confirms that all securities issues have been formally authorized by the Board of Directors and comply with the relevant legal requirements.
VIA BIOTECHNOLOGY HOLDINGS GROUP (THE “COMPANY”) FILED AN UPDATED SECURITIES CHANGE MONTH REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON FEBRUARY 2, 2024, REPORTING CHANGES IN COMPANY SHARES AS OF 31 JANUARY 2024. THE REPORT SHOWS THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL REMAINED UNCHANGED DURING THE REPORTING PERIOD, WITH 4,000,000,000 SHARES DEPOSITED AT THE END OF LAST MONTH AND DEPOSITS AT THE END OF THIS MONTH AT $0.000025 PER SHARE, AND THE TOTAL STATUTED/REGISTERED SHARE CAPITAL REMAINED AT $100,000. In addition, the number of share options under the Initial Public Offering Share Award Scheme and the Initial Public Post-IPO Share Option Plan remained unchanged during the month. The Company confirms that all securities issues have been formally authorized by the Board of Directors and comply with the relevant legal requirements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more